FDA Approves First US Biosimilar from Sandoz
March 6, 2015
Zachary Brennan
BioPharma-Reporter.com
Axinn Counsel Stacie Ropka was quoted in the BioPharma-Reporter.com article, "FDA Approves First US Biosimilar from Sandoz."
Click here to access the article.